drugset / Trial / NCT00828165
A Safety Study of ARRY-300 in Healthy Subjects
RandomizedCrossoverTriple-blindOther
Summary
This is a Phase 1 study, involving a 1-day dosing period (up to 3 dosing periods per subject), designed to test the safety of investigational study drug ARRY-300 in healthy subjects. Approximately 12 healthy subjects from the US will be enrolled in this study.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARRY-300 | Unknown | — | Oral |
Indications
No indication recorded.